Trials / Completed
CompletedNCT01666041
Vascular and Metabolic Effects of Fenofibrate/Omega vs Fenofibrate
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Gachon University Gil Medical Center · Academic / Other
- Sex
- All
- Age
- 25 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The investigators hypothesize that fenofibrate/omega will improve insulin resistance compared with fenofibrate
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | placebo | |
| DRUG | fenofibrate/omega | |
| DRUG | fenofibrate |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-02-01
- Completion
- 2013-07-01
- First posted
- 2012-08-16
- Last updated
- 2014-11-04
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01666041. Inclusion in this directory is not an endorsement.